A day before he was scheduled to give sworn testimony about his use of performance-enhancing drugs, Lance Armstrong reached a settlement Wednesday with an insurance company that was seeking $3 million in performance bonuses it paid him from 1999 to 2001.
A federal judge in California is siding with Lance Armstrong and the publishers of his autobiographies, rejecting claims in a lawsuit that lies about not using performance-enhancing drugs amounted to fraud and false advertising.
The Justice Department laid out its case in a lawsuit against Lance Armstrong on Tuesday, saying the cyclist violated his contract with the U.S. Postal Service and was "unjustly enriched" while cheating to win the Tour de France.
The Justice Department has joined a lawsuit against disgraced cyclist Lance Armstrong that alleges the former, seven-time Tour de France champion concealed his use of performance-enhancing drugs and defrauded his long-time sponsor.
The head of the U.S. Anti-Doping Agency lobbied Attorney General Eric Holder for the Justice Department to join a whistle-blower lawsuit against Lance Armstrong on the same day the cyclist confessed in an interview to performance-enhancing drug use.
Lance Armstrong does not intend to repay a Texas company that insured and paid bonuses for some of his Tour de France wins despite his admission that he used an array of performance-enhancing drugs in winning the titles, according to his attorney.
Danish rider Michael Rasmussen admitted Thursday that he took performance-enhancing drugs for more than a decade, the latest cyclist to acknowledge doping since Lance Armstrong's confession this month.